Susceptibility-Guided Therapy for Helicobacter Pylori Infection Treatment
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Hong Gao, MD
Fudan University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Huashan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Yi Liu, MDNot, yet, recruiting - Renji Hospital, School of Medicine, Shanghai Jiaotong University
Shanghai, Shanghai Municipality, China
Hong Lu, MDNot, yet, recruiting - Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, China
Chunmei Zhou, MDHong Gao, MDNingping Zhang, MDQi Chen, MDShenglei Huang, MDTiancheng Luo, MDWei Guo, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Mar 2022
- Primary completion
- 30 Dec 2022
- Completion
- 1 Mar 2023
- Last update posted
- 18 Mar 2022
- Registered enrollment
- 388
- Registry id
- NCT05250050
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.